Structure Therapeutics (GPCR) Operating Leases (2023 - 2026)
Quarterly Operating Leases fell 37.78% to $3.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Mar 2026, down 37.78% year-over-year, with the annual reading at $3.6 million for FY2025, 66.77% up from the prior year.
Structure Therapeutics' Operating Leases history spans 4 years, with the latest figure at $3.2 million for Q1 2026.
- Operating Leases came in at $3.2 million for Q1 2026, down from $3.6 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $5.1 million in Q1 2025 to a low of $2.2 million in Q4 2024.
- The 4-year median for Operating Leases is $3.5 million (2024), against an average of $3.6 million.
- Year-over-year, Operating Leases tumbled 46.08% in 2024 and then surged 66.77% in 2025.
- Structure Therapeutics' Operating Leases stood at $4.0 million in 2023, then crashed by 46.08% to $2.2 million in 2024, then soared by 66.77% to $3.6 million in 2025, then decreased by 11.8% to $3.2 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Operating Leases are $3.2 million (Q1 2026), $3.6 million (Q4 2025), and $4.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 4.29 Mn |
| Jun 30, 2025 | 5.01 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 4.01 Mn |
| Sep 30, 2023 | 3.03 Mn |